[PT(OX)(4CL-AZA)2];BIS-(4-CHLORO-7-AZAINDOLE)-KAPPA-N7-(OXALATO-KAPPA(2)-O,O')-PLATINUM-(II)
Compound with spectra: 2 NMR
![[PT(OX)(4CL-AZA)2];BIS-(4-CHLORO-7-AZAINDOLE)-KAPPA-N7-(OXALATO-KAPPA(2)-O,O')-PLATINUM-(II)](/api/compound/BTKP7cnUpgM.png?ph=true&h=300&w=458 "[PT(OX)(4CL-AZA)2];BIS-(4-CHLORO-7-AZAINDOLE)-KAPPA-N7-(OXALATO-KAPPA(2)-O,O')-PLATINUM-(II)")
| SpectraBase Compound ID | BTKP7cnUpgM |
|---|---|
| InChI | InChI=1S/2C7H5ClN2.C2H2O4.Pt/c2*8-6-2-4-10-7-5(6)1-3-9-7;3-1(4)2(5)6;/h2*1-4H,(H,9,10);(H,3,4)(H,5,6);/q;;;+2/p-2 |
| InChIKey | WAGDCHUTUFRBHC-UHFFFAOYSA-L |
| Mol Weight | 588.27 g/mol |
| Molecular Formula | C16H10Cl2N4O4Pt |
| Exact Mass | 586.972704 g/mol |
| Parent InChIKey | HNTZVGMWXCFCTA-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMF-D7 |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMF-D7 |
[PT(OX)(4BR-AZA)2];BIS-(4-BROMO-7-AZAINDOLE)-KAPPA-N7-(OXALATO-KAPPA(2)-O,O')-PLATINUM-(II)
2-Ethoxy-5-formyl-4-phenyl-6-(4-phenyl-1-piperidinyl)-3-pyridinecarbonitrile
1,2-DICHLORO-2-PHENYL-3,3-BIS(TRIFLUOROMETHYL)-4-HEXAFLUOROISOPROPYLIDENECYCLOBUTANE
7,8-dichloro-3-hydroxy-2-(2-thienyl)chromone
(3S,4S,5R,6R)-5-Nitro-3-pentyl-4,6-diphenylcyclohex-1-enecarbaldehyde
Ra-vii cyclic hexapeptide
#16;TERT.-BUTYL-6-[[(E)-1,1-DICHLORO-4-[(4-ETHOXYPHENYL)-AMINO]-3-NITRO-4-(1H-1,2,4-TRIAZOL-1-YL)-BUTA-1,3-DIEN-2-YL]-AMINO]-3-AZA-BICYCLO-[3.1.0]-HEXANE-3-CAR
GWJPWDLYQHKWLV-UHFFFAOYSA-N
9,10-Anthracenedione, 1,3-dimethoxy-8-methyl-
Ethyl 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis, Characterization and in Vitro Antitumor Activity of Platinum(II) Oxalato Complexes Involving 7-Azaindole Derivatives as Coligands | Molecules | 2014 |